Results
CORONA Remedies FY26 PAT Up 33.4% on 17.3% Revenue Growth
CORONA Remedies reported 17.3% YoY revenue growth to ₹1,403.2 Cr and 33.4% PAT growth to ₹199.4 Cr in FY26.
The company acquired WOKADINE to enter ₹648 Cr Povidone Iodine market and relaunched key bra
